These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 8070888)

  • 1. A pharmacokinetic model to describe toxicokinetic interactions between 1,3-butadiene and styrene in rats: predictions for human exposure.
    Filser JG; Johanson G; Kessler W; Kreuzer PE; Stei P; Baur C; Csanády GA
    IARC Sci Publ; 1993; (127):65-78. PubMed ID: 8070888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interaction between 1,3-butadiene and styrene in Sprague-Dawley rats.
    Laib RJ; Tucholski M; Filser JG; Csanády GA
    Arch Toxicol; 1992; 66(5):310-4. PubMed ID: 1610292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interspecies differences in metabolism and kinetics of 1,3-butadiene, isobutene and styrene.
    Bolt HM
    IARC Sci Publ; 1993; (127):37-44. PubMed ID: 8070883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research strategy for assessing target tissue dosimetry of 1,3-butadiene in laboratory animals and humans.
    Bond JA; Csanády GA; Leavens T; Medinsky MA
    IARC Sci Publ; 1993; (127):45-55. PubMed ID: 8070886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic toxicity of 1,3-butadiene and styrene.
    Norppa H; Sorsa M
    IARC Sci Publ; 1993; (127):185-93. PubMed ID: 8070865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic model describing the disposition of butadiene and styrene in mice.
    Leavens TL; Bond JA
    Toxicology; 1996 Oct; 113(1-3):310-3. PubMed ID: 8901915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,3-Butadiene: toxicity and carcinogenicity in laboratory animals and in humans.
    Melnick RL; Huff J
    Rev Environ Contam Toxicol; 1992; 124():111-44. PubMed ID: 1732994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotoxicity and cytotoxicity in male B6C3F1 mice following exposure to mixtures of 1,3-butadiene and styrene.
    Leavens TL; Farris GM; James RA; Shah R; Wong VA; Marshall MW; Bond JA
    Environ Mol Mutagen; 1997; 29(4):335-45. PubMed ID: 9212784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and metabolism of vinyl fluoride in vivo and in vitro.
    Cantoreggi S; Keller DA
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):130-9. PubMed ID: 9073601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene.
    Nauhaus SK; Fennell TR; Asgharian B; Bond JA; Sumner SC
    Chem Res Toxicol; 1996 Jun; 9(4):764-73. PubMed ID: 8831821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent kinetics of inhaled styrene in man.
    Löf A; Johanson G
    IARC Sci Publ; 1993; (127):89-99. PubMed ID: 8070890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans.
    Tardif R; Charest-Tardif G; Brodeur J; Krishnan K
    Toxicol Appl Pharmacol; 1997 May; 144(1):120-34. PubMed ID: 9169076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species-specific pharmacokinetics of styrene in rat and mouse.
    Filser JG; Schwegler U; Csanády GA; Greim H; Kreuzer PE; Kessler W
    Arch Toxicol; 1993; 67(8):517-30. PubMed ID: 8285850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of butadiene epoxides in Sprague-Dawley rats following exposures to 8000 ppm 1,3-butadiene: comparisons with tissue epoxide concentrations following low-level exposures.
    Thornton-Manning JR; Dahl AR; Allen ML; Bechtold WE; Griffith WC; Henderson RF
    Toxicol Sci; 1998 Feb; 41(2):167-73. PubMed ID: 9520352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose responses for the formation of hemoglobin adducts and urinary metabolites in rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-(14)C]-butadiene.
    Booth ED; Kilgour JD; Watson WP
    Chem Biol Interact; 2004 Mar; 147(2):213-32. PubMed ID: 15013822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of the metabolic fate of styrene.
    Sumner SJ; Fennell TR
    Crit Rev Toxicol; 1994; 24 Suppl():S11-33. PubMed ID: 7818768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Styrene-7,8-oxide burden in ventilated, perfused lungs of mice and rats exposed to vaporous styrene.
    Hofmann C; Pütz C; Semder B; Faller TH; Csanády GA; Filser JG
    Toxicol Sci; 2006 Mar; 90(1):39-48. PubMed ID: 16322077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologically based modeling of the inhalation kinetics of styrene in humans using a bayesian population approach.
    Jonsson F; Johanson G
    Toxicol Appl Pharmacol; 2002 Feb; 179(1):35-49. PubMed ID: 11884235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.